CYCLACEL PHARMACEUTICALS

Cyclacel Pharmaceuticals, Inc. is a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases. Professor Sir David Lane, a recognized leader in the field of tumor suppressor biology, who discovered the p53 protein, founded the Company in 1996. In 1999, Cyclacel Pharmaceuticals was joined by Professor David Glover, a recognized leader in the mechanism of mitosis or cell division, who discovered, among other cell cycle targets, the mitotic kinases, Polo and Aurora, enzymes that act in the mitosis phase of the cell cycle.

#SimilarOrganizations #People #Financial #Website #More

CYCLACEL PHARMACEUTICALS

Industry:

Biotechnology Health Care Pharmaceutical Therapeutics

Founded:

1996-01-01

Address:

Berkeley Heights, New Jersey, United States

Country:

United States

Website Url:

http://www.cyclacel.com

Total Employee:

11+

Status:

Active

Contact:

+1 (908) 517 7330

Email Addresses:

[email protected]

Total Funding:

166.73 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Domain Not Resolving

Similar Organizations

aclaris-therapeutics-logo

Aclaris Therapeutics

Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.

adamas-pharmaceuticals-logo

Adamas Pharmaceuticals

Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.

akebia-therapeutics-logo

Akebia Therapeutics

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

aveo-oncology-logo

AVEO Oncology

AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.

avid-radiopharmaceuticals-logo

Avid Radiopharmaceuticals

Avid Radiopharmaceuticals develops molecular imaging agents for detecting and monitoring chronic human diseases.

cognition-therapeutics-logo

Cognition Therapeutics

Cognition Therapeutics develops new therapeutics to treat patients suffering from Alzheimer’s disease and other neurodegenerative disorders.

jounce-therapeutics-logo

Jounce Therapeutics

Jounce Therapeutics is developing cancer immune-therapies to harness the immune system to attack cancerous cells and tumors.

pacylex-logo

Pacylex

Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.

rigel-pharmaceuticals-logo

Rigel Pharmaceuticals

Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.

taris-biomedical-logo

TARIS Biomedical

TARIS Biomedical is a pharmaceutical company developing therapies for genitourinary system issues.

Current Advisors List

robert-spiegel_image

Robert Spiegel Board Of Directors @ Cyclacel Pharmaceuticals
Board_member
2018-09-01

nicholas-bacopoulos_image

Nicholas Bacopoulos Board of Directors @ Cyclacel Pharmaceuticals
Board_member

Current Employees Featured

not_available_image

David Glover
David Glover Chief Scientist LOfficer @ Cyclacel Pharmaceuticals
Chief Scientist LOfficer

not_available_image

Spiro Rombotis
Spiro Rombotis President and Chief Executive Officer @ Cyclacel Pharmaceuticals
President and Chief Executive Officer

david-lane_image

David Lane
David Lane Founder @ Cyclacel Pharmaceuticals
Founder

goro-takeda_image

Goro Takeda
Goro Takeda Investor @ Cyclacel Pharmaceuticals
Investor

not_available_image

Paul McBarron
Paul McBarron Executive Vice President, Finance and Chief Operating Officer and Secretary @ Cyclacel Pharmaceuticals
Executive Vice President, Finance and Chief Operating Officer and Secretary